×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Best Practices in Governance Meetings
Session Chair(s)
Nathan Kreischer, MS, PMP
Director, Global Project & Alliance Management
Merck & Co. Inc., United States
This session will discuss best practices and key success factors for enabling and maximizing the effectiveness of interactions with Governance boards. Governance structures and key elements will be examined and compared from multiple viewpoints including CRO, pharma, and biotech.
Learning Objective : Describe the governance structures and team interactions which occur in different sectors of the industry; Discuss key elements and best practices which maximize the effectiveness of the interactions and result in high-performance outcomes including trust and transparency, identification of key performance indicators, clear definition and communication of priorities, alignment between the strategy and execution, and unambiguous decision making.
Speaker(s)
Best Practices in Governance: Big Pharma
Nathan Kreischer, MS, PMP
Merck & Co. Inc., United States
Director, Global Project & Alliance Management
Best Practices in Governance: Contract Research Organization (CRO)
Melissa Mauriber
Advanced Clinical, United States
VP, Clinical Operations Quality & Talent Development
Best Practices in Governance: Small Biotech
Leann Frankel, MPH
Gates Medical Research Institute, United States
Strategic Sourcing Lead - Clinical Operations
Have an account?